Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells
- PMID: 26622665
- PMCID: PMC4533726
- DOI: 10.3892/ol.2015.3468
Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells
Abstract
The mechanisms underlying drug resistance in colorectal cancer (CRC) treatment remain to be fully elucidated. Therefore, the present study aimed to investigate the underlying mechanism resistance to a widely used anticancer drug, 5-Fluorouracil (5-FU). Nuclear factor-erythroid 2-related factor 2 (Nrf2) is an important transcription factor involved in cellular protection. In the present study, it was hypothesized that the epigenetic modification of Nrf2 may be a potential target for 5-FU resistance in CRC treatment. Protein and messenger RNA levels of Nrf2, heme oxygenase-1 (HO-1), DNA methylases and DNA methyltransferases were determined and DNA methylation analysis for the Nrf2 promoter was performed in a human CRC control (SNU-C5) and resistant (SNU-C5R) cell line. The results demonstrated that Nrf2 expression levels, nuclear translocation and promoter binding were significantly increased in SNU-C5R cells compared with SNU-C5 cells. Elevated levels of activated Nrf2 in SNU-C5R cells resulted in the increased protein expression and activity of HO-1. In addition, increased production of reactive oxygen species (ROS) and upregulation of ten-eleven translocation (TET)1 were observed in SNU-C5R cells compared with SNU-C5 cells. Furthermore, methylation analysis revealed Nrf2 promoter cytosine-phosphate-guanine island hypomethylation in 5-FU-treated cells. In conclusion, the results indicated that 5-FU-induced ROS production resulted in the upregulation of TET1 expression and function. In addition, these results indicated that TET-dependent demethylation of the Nrf2 promoter upregulated Nrf2 and HO-1 expression, which induced cellular protection mechanisms, ultimately leading to drug resistance.
Keywords: 5-fluorouracil; SNU-C5 cells; colorectal cancer; cytosine-phosphate-guanine islands; epigenetics.
Figures
Similar articles
-
Role of NRF2 in Colorectal Cancer Prevention and Treatment.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221105736. doi: 10.1177/15330338221105736. Technol Cancer Res Treat. 2022. PMID: 36476179 Free PMC article. Review.
-
FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.Cancer Lett. 2020 Feb 1;470:29-42. doi: 10.1016/j.canlet.2019.11.042. Epub 2019 Dec 4. Cancer Lett. 2020. PMID: 31811910
-
Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells.Oncotarget. 2018 Apr 13;9(28):19911-19928. doi: 10.18632/oncotarget.24952. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29731993 Free PMC article.
-
Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells.Oncotarget. 2016 Jun 28;7(26):40594-40620. doi: 10.18632/oncotarget.9745. Oncotarget. 2016. PMID: 27259240 Free PMC article.
-
Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.Cell Death Dis. 2014 Apr 17;5(4):e1183. doi: 10.1038/cddis.2014.149. Cell Death Dis. 2014. PMID: 24743738 Free PMC article.
Cited by
-
Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer.Front Cell Dev Biol. 2023 Dec 21;11:1291179. doi: 10.3389/fcell.2023.1291179. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38188020 Free PMC article.
-
NFR2/ABC transporter axis in drug resistance of breast cancer cells.Mol Biol Rep. 2023 Jun;50(6):5407-5414. doi: 10.1007/s11033-023-08384-7. Epub 2023 Apr 20. Mol Biol Rep. 2023. PMID: 37081307 Review.
-
Effects of the juçara fruit (Euterpe edulis Martius) pulp and lyophilized extract on NRF2, KEAP1, SOD1, and GPX2 expression in human colorectal cancer cell lines.Braz J Med Biol Res. 2023 Apr 14;56:e12558. doi: 10.1590/1414-431X2023e12558. eCollection 2023. Braz J Med Biol Res. 2023. PMID: 37075346 Free PMC article.
-
Role of NRF2 in Colorectal Cancer Prevention and Treatment.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221105736. doi: 10.1177/15330338221105736. Technol Cancer Res Treat. 2022. PMID: 36476179 Free PMC article. Review.
-
Clinical Significance of Heme Oxygenase 1 in Tumor Progression.Antioxidants (Basel). 2021 May 17;10(5):789. doi: 10.3390/antiox10050789. Antioxidants (Basel). 2021. PMID: 34067625 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous